Citation: | CHEN Xi, REN Chao, WANG Haiyan, DONG Aiqiao. Application value of extracorporeal auxiliary instruments in treatment of patients with fulminant myocarditis[J]. Journal of Clinical Medicine in Practice, 2021, 25(24): 57-59, 64. DOI: 10.7619/jcmp.20214475 |
[1] |
中华医学会心血管病学分会精准医学学组, 中华心血管病杂志编辑委员会, 成人暴发性心肌炎工作组. 成人暴发性心肌炎诊断与治疗中国专家共识[J]. 内科急危重症杂志, 2017, 23(6): 443-453. https://www.cnki.com.cn/Article/CJFDTOTAL-NKJW201706002.htm
|
[2] |
KOCIOL R D, COOPER L T, FANG J C, et al. Recognition and initial management of fulminant myocarditis: a scientific statement from the American heart association[J]. Circulation, 2020, 141(6): e69-e92. http://www.ingentaconnect.com/content/wk/cir/2020/00000141/00000006/art00003
|
[3] |
LI S, XU S, LI C, et al. A life support-based comprehensive treatment regimen dramatically lowers the in-hospital mortality of patients with fulminant myocarditis: a multiple center study[J]. Sci China Life Sci, 2019, 62(3): 369-380. doi: 10.1007/s11427-018-9501-9
|
[4] |
CHENG R, HACHAMOVITCH R, KITTLESON M, et al. Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1, 866 adult patients[J]. Ann Thorac Surg, 2014, 97(2): 610-616. doi: 10.1016/j.athoracsur.2013.09.008
|
[5] |
KIM I A, YANG H S, KIM W S, et al. Pathological substratum for a case of fulminant myocarditis treated with extracorporeal membrane oxygenation and subsequent heart transplantation[J]. J Korean Med Sci, 2015, 30(9): 1367. doi: 10.3346/jkms.2015.30.9.1367
|
[6] |
LORUSSO R, CENTOFANTI P, GELSOMINO S, et al. Venoarterial extracorporeal membrane oxygenation for acute fulminant myocarditis in adult patients: a 5-year multi-institutional experience[J]. Ann Thorac Surg, 2016, 101(3): 919-926. doi: 10.1016/j.athoracsur.2015.08.014
|
[7] |
DIDDLE J W, ALMODOVAR M C, RAJAGOPAL S K, et al. Extracorporeal membrane oxygenation for the support of adults with acute myocarditis[J]. Crit Care Med, 2015, 43(5): 1016-1025. doi: 10.1097/CCM.0000000000000920
|
[8] |
NAKAMURA T, ISHIDA K, TANIGUCHI Y, et al. Prognosis of patients with fulminant myocarditis managed by peripheral venoarterial extracorporeal membranous oxygenation support: a retrospective single-center study[J]. J Intensive Care, 2015, 3(1): 5. doi: 10.1186/s40560-014-0069-9
|
[9] |
辜刚建, 秦臻, 罗明, 等. 体外膜肺氧合在急性爆发性心肌炎治疗中的应用[J]. 中国体外循环杂志, 2017, 15(4): 252-256. https://www.cnki.com.cn/Article/CJFDTOTAL-TWXH201704019.htm
|
[10] |
盛楚乔, 张圳, 李玉梅, 等. 连续性血液净化治疗儿童暴发性心肌炎疗效观察[J]. 中国当代儿科杂志, 2015, 17(6): 638-641. https://www.cnki.com.cn/Article/CJFDTOTAL-DDKZ201506024.htm
|
[11] |
SANKAR J, KHALIL S, JEEVA SANKAR M, et al. Short-term outcomes of acute fulminant myocarditis in children[J]. Pediatr Cardiol, 2011, 32(7): 885-890. doi: 10.1007/s00246-011-0007-8
|
[12] |
李杰, 赵娜. 暴发性心肌炎儿童连续性肾脏替代治疗的心肌损害标志物与左心室射血分数的关系[J]. 岭南心血管病杂志, 2019, 25(6): 687-690, 712. https://www.cnki.com.cn/Article/CJFDTOTAL-LXGB201906021.htm
|
[13] |
丘国政, 吕立文, 朱瑞凯, 等. 体外膜肺氧合在急性暴发性心肌炎中的临床应用及效果分析[J]. 中国临床新医学, 2021, 14(5): 437-440. doi: 10.3969/j.issn.1674-3806.2021.05.03
|
1. |
朱国玉,吴洋,秦陈,张晓春,李文骥. 中老年Ⅱ~Ⅲ期胃癌患者预后预测列线图模型的构建和验证. 实用临床医药杂志. 2024(17): 27-34+40 .
![]() | |
2. |
朱婷,周海兰,华骁帆. 基于多维度指标预测乳腺癌术后复发的列线图模型建立及应用. 实用临床医药杂志. 2023(05): 43-48 .
![]() | |
3. |
林建琴,蒋田华,於晓平,祝娉婷. 乳腺癌患者经外周静脉置入中心静脉导管维护依从性影响因素及精准护理效果分析. 实用临床医药杂志. 2023(16): 142-148 .
![]() |